Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.
ClinicalTrials.gov study NCT01972217. IPD Sharing: YES. Countries: 11. Publications: 2.
Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01511536. IPD Sharing: Not stated. Countries: 3. Publications: 2.
ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT03456804. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)
ClinicalTrials.gov study NCT02985957. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT01522443. IPD Sharing: Not stated. Countries: 5. Publications: 4.
Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
ClinicalTrials.gov study NCT02987543. IPD Sharing: Not stated. Countries: 20. Publications: 7.
A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)
ClinicalTrials.gov study NCT02034552. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)
ClinicalTrials.gov study NCT00945139. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT03414034. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01505868. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer
ClinicalTrials.gov study NCT01799278. IPD Sharing: NO. Countries: 1. Publications: 1.
Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer
ClinicalTrials.gov study NCT02430480. IPD Sharing: YES. Countries: 1. Publications: 4.
An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT03338790. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02215096. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)
ClinicalTrials.gov study NCT03834519. IPD Sharing: YES. Countries: 20. Publications: 2.
A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)
ClinicalTrials.gov study NCT01090765. IPD Sharing: NO. Countries: 1. Publications: 3.
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT00976911. IPD Sharing: Not stated. Countries: 14. Publications: 7.
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
ClinicalTrials.gov study NCT02861300. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT03732820. IPD Sharing: Not stated. Countries: 17. Publications: 6.
Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
ClinicalTrials.gov study NCT01940276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.